High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: Cysteine-rich V-specific domain is required for high resistance to the interferons

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9165-9176

  Nishio, M ^a   Tsurudome, M ^a   Ito, M ^a   Kawano, M ^a   Komada, H ^a   Ito, Y ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYSTEINE; HPIV 2 PROTEIN; MESSENGER RNA; PROTEASOME INHIBITOR; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOMODULATION; PARAINFLUENZA VIRUS 2; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSLATION; SINDBIS VIRUS; TRANSCRIPTION REGULATION; VESICULAR STOMATITIS VIRUS; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CELL DIVISION; CYSTEINE; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; HELA CELLS; HUMANS; INTERFERONS; PARAINFLUENZA VIRUS 2, HUMAN; RUBULAVIRUS INFECTIONS; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 0034844039     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9165-9176.2001     Document Type: Article

References (37)

1. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons
2. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection
3. A full-length murine 2′-5′A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication
4. Sendai virus and simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis
5. The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for protease-mediated degradation
6. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state
7. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses
8. Inhibition of interferon by an infection with parainfluenza virus type 3 (PIV-3)
9. Interferon production in L cells persistently infected with hemagglutinating virus of Japan (HVJ)
10. Temperature sensitivity of interferon susceptibility in L cells persistently infected with hemagglutinating virus of Japan (HVJ)
11. Interferon susceptibility of various cell lines persistently infected with haemagglutinating virus of Japan (HVJ)
12. HN proteins of human parainfluenza type 4A virus expressed in cell lines transfected with a cloned cDNA have an ability to induce interferon α/β in mouse spleen cells
13. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain
14. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
15. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein
16. Growth of Newcastle disease virus in a HVJ carrier culture of HeLa cells
17. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells
18. Interferon action. III. The rate of primary transcription of vesicular stomatitis virus is inhibited by interferon action
19. Activation of the transcription factor ISGF3 by interferon-gamma
20. A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos
21. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
22. Interferon induction of TAP1: The phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways
23. Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: One of the two NP binding sites on P is essential for granule formation
24. Human parainfluenza virus type 2 phosphoprotein: Mapping of monoclonal antibody epitopes and location of the multimerization domain
25. Isolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells
26. Sequence analysis of P gene of human parainfluenza type 2 virus: P and cysteine-rich proteins are translated by two mRNAs that differ by two nontemplated G residues
27. V and C proteins of measles virus function as virulence factors in vivo
28. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities
29. Interferon alters intracellular transport of vesicular stomatitis virus glycoprotein
30. How cells respond to interferons
31. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors
32. Extensive antigenic diversity among human type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies
33. Mechanism of interferon action: Inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned γ-interferon. I. Effect on viral macromolecular synthesis
34. Identification of the sequences responsible for nuclear targeting of the V protein of human parainfluenza virus type 2
35. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (1SGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to IFN-α/β
36. Poor induction of interferon-induced 2′,5′-oligoadenylate synthetase (2-FAS) in cells persistently infected with mumps virus is caused by decrease of STAT-1α
37. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response